PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.42%
Net income growth under 50% of ADI's 18.86%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
1.87%
D&A growth well above ADI's 2.29%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
46.15%
Some yoy growth while ADI is negative at -322.60%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
79.32%
Well above ADI's 95.71% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
100.00%
AR growth of 100.00% while ADI is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-28.26%
Negative yoy inventory while ADI is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
100.00%
AP growth of 100.00% while ADI is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
237.84%
Growth well above ADI's 95.71%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-219.05%
Negative yoy while ADI is 73.93%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
92.86%
Operating cash flow growth above 1.5x ADI's 1.90%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-22.73%
Negative yoy CapEx while ADI is 4.05%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-1.22%
Both yoy lines negative, with ADI at -15.57%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-18.70%
Both yoy lines are negative, with ADI at -14.96%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
-8900.00%
Both yoy lines negative, with ADI at -205.90%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while ADI is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
193.75%
Stock issuance far above ADI's 33.59%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-27.08%
We cut yoy buybacks while ADI is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.